Start Your NewsReadery Pro FREE TRIAL!
Register and verify your email address to start your
NewsReadery Pro FREE TRIAL
today!
Login / Register
Actions
Newsfeed
Popular
Local
Discover
Follows
Blocks
Bookmarks
Filters
Settings
PowerUps
Help
Updates
Login / Register
zacks.com
/
Share Newsitem
View, share or embed this newsitem using the details below.
Zacks Investment Research: Stock Research, Analysis, & Recommendations
@zacks.com
/
2 days
2d
Follow
AZN's Tagrisso Gets Approval in the EU for Expanded Use in NSCLC
AstraZeneca wins approval in the EU for the label expansion of Tagrisso to treat adult patients with locally advanced, unresectable NSCLC.
https://newsreadery.com/go/fa13b2ece13ab00f56db3f26412b86df
Save
Share
Share this Newsitem URL
Embed this Newsitem
<div class="readery-embed readery-embed-fa13b2ece13ab00f56db3f26412b86df"></div><script async src="https://open.newsreadery.com/oembed?format=html&url=https%3A%2F%2Fnewsreadery.com%2Fitem%2Ffa13b2ece13ab00f56db3f26412b86df" charset="utf-8"></script>
Back
Read Full Article
Continue
Please wait ...
